Ideomotor Apraxia
10
relevant articles (1 outcomes,
3 trials/studies)
found for this Disease
Description:
A form of APRAXIA characterized by an acquired inability to carry out a complex motor activity despite the ability to mentally formulate the action. This condition has been attributed to a disruption of connections between the dominant parietal cortex and supplementary and premotor cortical regions in both hemispheres. (From Adams et al., Principles of Neurology, 6th ed, p57)
Also Known As:
Apraxia, Ideomotor; Apraxia, Ideokinetic; Apraxia, Limb Kinetic; Apraxia, Transcortical; Classic Apraxia; Apraxia, Classic; Apraxias, Classic; Apraxias, Ideokinetic; Apraxias, Ideomotor; Apraxias, Limb Kinetic; Apraxias, Transcortical; Classic Apraxias; Dyspraxias, Ideomotor; Ideokinetic Apraxia; Ideokinetic Apraxias; Ideomotor Apraxias; Ideomotor Dyspraxia; Ideomotor Dyspraxias; Kinetic Apraxia, Limb; Kinetic Apraxias, Limb; Limb Kinetic Apraxia; Limb Kinetic Apraxias; Transcortical Apraxia; Transcortical Apraxias; Dyspraxia, Ideomotor
Relationship Network
Disease Context: Research Results
Related Diseases
Drugs and Biologics
Drugs and Important Biological Agents (IBA) related to Ideomotor Apraxia:
| 1. | Amantadine (Aman)FDA LinkGeneric
|
| 2. | Levodopa (L Dopa)FDA LinkGeneric
05/01/1991
- " The group with frozen gait (4 cases, aged 78 to 82 years) which failed to respond to L-dopa therapy, had no limb-kinetic apraxia or frontal signs, but did exhibit "kinésie paradoxale"" 02/01/1998
- " CONCLUSION: The results confirm that unilateral parkinsonism unresponsive to levodopa and limb ideomotor apraxia are the clinical hallmarks of corticobasal degeneration, and only a minority of patients with corticobasal degeneration present with dementia" 05/01/2004
- " Atypical parkinsonism (AP) is a term applied to disorders characterized by parkinsonism that evolves rapidly, with poor or transient response to levodopa, or has other associated features such as early falls and postural instability, early autonomic failure, supranuclear gaze palsy, pyramidal or cerebellar signs, alien hand syndrome or severe ideomotor apraxia" 08/01/2001
- " L-dopa had no effect on the symptoms of rigidity, limb kinetic apraxia, cortical sensory loss, ideomotor apraxia, and dressing apraxia"
Order ALL the reference details at left...
|
| 3. | Amyloid (Amyloid Fibrils)IBA
01/01/2001
- " Compared with the other groups, pDLB cases had more frequent acute-subacute onset of dementia [45% vs. AD (3%) and AD+LB (16%)], early parkinsonism [45% vs. AD (0%) and AD+LB (0%)], early [27% vs. AD (0%) and AD+LB (0%)] and late [73% vs. AD (11%) and AD+LB (16%)] hallucinations, fluctuating course [46% vs. AD (9%) and AD+LB (22%)], delusions [45% vs. AD (11%) and AD+LB (6%)], spontaneous parkinsonism [63% vs. AD (8%) and AD+LB (16%)], less frequent ideomotor apraxia and loss of insight, earlier urinary incontinence [3.2 +/- 1.4 years after onset vs. AD (6.3 years) and AD+LB (5.8 years)], shorter duration of dementia [7.7 +/- 2.4 years vs. AD (9.6 years) and AD+LB (11 years)], milder atrophy in computed tomography scans, greater brain weight, more transcortical spongiosis, wider cortex and subcortex, and less amyloid angiopathy"
Order ALL the reference details at left...
|
| 4. | propyl O-beta galactopyranosyl-(1-4)-O-beta galactopyranosyl-(1-4)-alpha galactopyranosideIBA
|
| 5. | AD 11IBA
01/01/2001
- " Compared with the other groups, pDLB cases had more frequent acute-subacute onset of dementia [45% vs. AD (3%) and AD+LB (16%)], early parkinsonism [45% vs. AD (0%) and AD+LB (0%)], early [27% vs. AD (0%) and AD+LB (0%)] and late [73% vs. AD (11%) and AD+LB (16%)] hallucinations, fluctuating course [46% vs. AD (9%) and AD+LB (22%)], delusions [45% vs. AD (11%) and AD+LB (6%)], spontaneous parkinsonism [63% vs. AD (8%) and AD+LB (16%)], less frequent ideomotor apraxia and loss of insight, earlier urinary incontinence [3.2 +/- 1.4 years after onset vs. AD (6.3 years) and AD+LB (5.8 years)], shorter duration of dementia [7.7 +/- 2.4 years vs. AD (9.6 years) and AD+LB (11 years)], milder atrophy in computed tomography scans, greater brain weight, more transcortical spongiosis, wider cortex and subcortex, and less amyloid angiopathy"
Order ALL the reference details at left...
|
| 6. | GATIBA
|
| 7. | 2-methylcyclopentadienyl manganese tricarbonyl (MMT)IBA
|
|
Therapies and Procedures
| 1. | Activities of Daily Living (ADL)
06/01/2008
- " The aim of this study was to investigate the effect of ideomotor apraxia on activities of daily living and to determine if the presence of apraxia interferes with rehabilitation" 03/01/2003
- " The following factors were found in one level A study: initial ADL disability and ambulation, high age, severe paresis or paralysis, impaired swallowing, ideomotor apraxia, ideational apraxia, and visuospatial construction problems; as well as factors relating to complications of an ischaemic stroke, such as extraparenchymal bleeding, cerebral oedema and size of intraparenchymal haemorrhage" 06/01/2008
- " All the patients were assessed at their admission and discharge, respectively, for apraxia by Ideomotor Apraxia Test, for daily living activities by Functional Independence Measure (FIM, Santa Clara Valley Medical Center, San Jose, California, USA), for cognitive functions by Mini Mental State Examination (MMSE), and for language components by Gulhane Aphasia Test (GAT)"
Order ALL the reference details at left...
|
| 2. | Walking
|
| 3. | Anesthesia
|
|
